COVID-19 Increases Autoimmune Blistering Disease Risk, Study Finds
Conexiant
March 6, 2025
COVID-19 infections are linked to a 50.8% increased risk of autoimmune blistering diseases (AIBD), particularly pemphigus.
COVID-19 vaccination is associated with nearly halved risk of AIBD, with the most significant reduction observed for pemphigus.
Patients with prior COVID-19 infections have over a threefold increased risk of AIBD compared to vaccinated individuals.
The study utilized TriNetX, accessing over 112 million electronic health records to assess AIBD incidence.
The study's retrospective design has limitations, including potential underreporting of COVID-19 cases and misclassification of AIBD.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: